Skip to main content
Top
Published in: Pediatric Cardiology 2/2018

01-02-2018 | Original Article

RCAN1 Mutation and Functional Characterization in Children with Sporadic Congenital Heart Disease

Authors: Xiaoyong Li, Lei Shi, Ming Xu, Xun Zheng, Yiwen Yu, Jing Jin

Published in: Pediatric Cardiology | Issue 2/2018

Login to get access

Abstract

Congenital heart disease (CHD) is the most frequent birth defect. RCAN1 (regulator of calcineurin 1) contributes to CHD in Down syndrome. However, whether RCAN1 is also associated with nonsyndromic CHD remains unclear. This study sequenced the exons and flanking region of RCAN1 in 128 sporadic CHD patients and 150 normal controls. We identified six novel heterozygous mutations in CHD patients. Functional assay showed that the g.482G>T could obviously raise the promoter activity of RCAN1.4 in vitro; However, we failed to detect the expression of RCAN1 in the right auricle, which made it confused to evaluate the pathogenicity of this mutation. In addition, we demonstrated that c.290T>C and g.1056+58C>A had no effect on the alternative splicing of RCAN1. The *196C>T, *790G>A, and *1278C>G did not influence the translation of RCAN1 post transcription. In conclusion, a novel mutation of g.482G>T in RCAN1 may be related to CHD by causing overexpression of RCAN1.4.
Literature
1.
go back to reference van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, Roos-Hesselink JW (2011) Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58:2241–2247CrossRefPubMed van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, Roos-Hesselink JW (2011) Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58:2241–2247CrossRefPubMed
2.
go back to reference Fahed AC, Gelb BD, Seidman JG, Seidman CE (2013) Genetics of congenital heart disease: the glass half empty. Circ Res 112:707–720CrossRefPubMed Fahed AC, Gelb BD, Seidman JG, Seidman CE (2013) Genetics of congenital heart disease: the glass half empty. Circ Res 112:707–720CrossRefPubMed
3.
go back to reference Clark KL, Yutzey KE, Benson DW (2006) Transcription factors and congenital heart defects. Annu Rev Physiol 68:97–121CrossRefPubMed Clark KL, Yutzey KE, Benson DW (2006) Transcription factors and congenital heart defects. Annu Rev Physiol 68:97–121CrossRefPubMed
4.
go back to reference Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, Giglia TM, Goldmuntz E, McGee G, Sable CA, Srivastava D, Webb CL (2007) American Heart Association Congenital Cardiac Defects Committee CoCDitY, Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115:3015–3038CrossRefPubMed Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, Giglia TM, Goldmuntz E, McGee G, Sable CA, Srivastava D, Webb CL (2007) American Heart Association Congenital Cardiac Defects Committee CoCDitY, Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115:3015–3038CrossRefPubMed
5.
go back to reference Elmagrpy Z, Rayani A, Shah A, Habas E, Aburawi EH (2011) Down syndrome and congenital heart disease: why the regional difference as observed in the Libyan experience? Cardiovasc J Afr 22:306–309CrossRefPubMedPubMedCentral Elmagrpy Z, Rayani A, Shah A, Habas E, Aburawi EH (2011) Down syndrome and congenital heart disease: why the regional difference as observed in the Libyan experience? Cardiovasc J Afr 22:306–309CrossRefPubMedPubMedCentral
6.
go back to reference Baraona F, Gurvitz M, Landzberg MJ, Opotowsky AR (2013) Hospitalizations and mortality in the United States for adults with Down syndrome and congenital heart disease. Am J Cardiol 111:1046–1051CrossRefPubMed Baraona F, Gurvitz M, Landzberg MJ, Opotowsky AR (2013) Hospitalizations and mortality in the United States for adults with Down syndrome and congenital heart disease. Am J Cardiol 111:1046–1051CrossRefPubMed
7.
go back to reference Casas C, Martinez S, Pritchard MA, Fuentes JJ, Nadal M, Guimera J, Arbones M, Florez J, Soriano E, Estivill X, Alcantara S (2001) Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis. Mech Dev 101:289–292CrossRefPubMed Casas C, Martinez S, Pritchard MA, Fuentes JJ, Nadal M, Guimera J, Arbones M, Florez J, Soriano E, Estivill X, Alcantara S (2001) Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis. Mech Dev 101:289–292CrossRefPubMed
8.
go back to reference Kim SS, Seo SR (2011) The regulator of calcineurin 1 (RCAN1/DSCR1) activates the cAMP response element-binding protein (CREB) pathway. J Biol Chem 286:37841–37848CrossRefPubMedPubMedCentral Kim SS, Seo SR (2011) The regulator of calcineurin 1 (RCAN1/DSCR1) activates the cAMP response element-binding protein (CREB) pathway. J Biol Chem 286:37841–37848CrossRefPubMedPubMedCentral
9.
go back to reference Barlow GM, Chen XN, Shi ZY, Lyons GE, Kurnit DM, Celle L, Spinner NB, Zackai E, Pettenati MJ, Van Riper AJ, Vekemans MJ, Mjaatvedt CH, Korenberg JR (2001) Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet Med 3:91–101CrossRefPubMed Barlow GM, Chen XN, Shi ZY, Lyons GE, Kurnit DM, Celle L, Spinner NB, Zackai E, Pettenati MJ, Van Riper AJ, Vekemans MJ, Mjaatvedt CH, Korenberg JR (2001) Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet Med 3:91–101CrossRefPubMed
10.
go back to reference Li X, Wang G, An Y, Li H, Li Y, Wu C (2015) Association between sequence variations in RCAN1 promoter and the risk of sporadic congenital heart disease in a Chinese population. Pediatr Cardiol 36:1393–1399CrossRefPubMed Li X, Wang G, An Y, Li H, Li Y, Wu C (2015) Association between sequence variations in RCAN1 promoter and the risk of sporadic congenital heart disease in a Chinese population. Pediatr Cardiol 36:1393–1399CrossRefPubMed
11.
go back to reference Ogino S, Gulley ML, den Dunnen JT, Wilson RB (2007) Association for Molecular Pathology T, Education C. Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. J Mol Diagn 9:1–6CrossRefPubMedPubMedCentral Ogino S, Gulley ML, den Dunnen JT, Wilson RB (2007) Association for Molecular Pathology T, Education C. Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. J Mol Diagn 9:1–6CrossRefPubMedPubMedCentral
12.
go back to reference Wu Y, Song W (2013) Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis. FASEB J 27:208–221CrossRefPubMed Wu Y, Song W (2013) Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis. FASEB J 27:208–221CrossRefPubMed
13.
go back to reference Bhoiwala DL, Koleilat I, Qian J, Beyer B, Hushmendy SF, Mathew A, Bhoiwala DL, Ferland RJ, Crawford DR (2013) Overexpression of RCAN1 isoform 4 in mouse neurons leads to a moderate behavioral impairment. Neurol Res 35:79–89CrossRefPubMed Bhoiwala DL, Koleilat I, Qian J, Beyer B, Hushmendy SF, Mathew A, Bhoiwala DL, Ferland RJ, Crawford DR (2013) Overexpression of RCAN1 isoform 4 in mouse neurons leads to a moderate behavioral impairment. Neurol Res 35:79–89CrossRefPubMed
14.
go back to reference Sun X, Wu Y, Chen B, Zhang Z, Zhou W, Tong Y, Yuan J, Xia K, Gronemeyer H, Flavell RA, Song W (2011) Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation. J Biol Chem 286:9049–9062CrossRefPubMedPubMedCentral Sun X, Wu Y, Chen B, Zhang Z, Zhou W, Tong Y, Yuan J, Xia K, Gronemeyer H, Flavell RA, Song W (2011) Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation. J Biol Chem 286:9049–9062CrossRefPubMedPubMedCentral
15.
go back to reference Martin KR, Corlett A, Dubach D, Mustafa T, Coleman HA, Parkington HC, Merson TD, Bourne JA, Porta S, Arbones ML, Finkelstein DI, Pritchard MA (2012) Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory. Hum Mol Genet 21:3025–3041CrossRefPubMed Martin KR, Corlett A, Dubach D, Mustafa T, Coleman HA, Parkington HC, Merson TD, Bourne JA, Porta S, Arbones ML, Finkelstein DI, Pritchard MA (2012) Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory. Hum Mol Genet 21:3025–3041CrossRefPubMed
16.
go back to reference Martin KR, Layton D, Seach N, Corlett A, Barallobre MJ, Arbones ML, Boyd RL, Scott B, Pritchard MA (2013) Upregulation of RCAN1 causes Down syndrome-like immune dysfunction. J Med Genet 50:444–454CrossRefPubMed Martin KR, Layton D, Seach N, Corlett A, Barallobre MJ, Arbones ML, Boyd RL, Scott B, Pritchard MA (2013) Upregulation of RCAN1 causes Down syndrome-like immune dysfunction. J Med Genet 50:444–454CrossRefPubMed
17.
go back to reference Sobrado M, Ramirez BG, Neria F, Lizasoain I, Arbones ML, Minami T, Redondo JM, Moro MA, Cano E (2012) Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury. J Neuroinflammation 9:48CrossRefPubMedPubMedCentral Sobrado M, Ramirez BG, Neria F, Lizasoain I, Arbones ML, Minami T, Redondo JM, Moro MA, Cano E (2012) Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury. J Neuroinflammation 9:48CrossRefPubMedPubMedCentral
18.
go back to reference Fuentes JJ, Genesca L, Kingsbury TJ, Cunningham KW, Perez-Riba M, Estivill X, de la Luna S (2000) DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9:1681–1690CrossRefPubMed Fuentes JJ, Genesca L, Kingsbury TJ, Cunningham KW, Perez-Riba M, Estivill X, de la Luna S (2000) DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9:1681–1690CrossRefPubMed
19.
go back to reference Ranger AM, Grusby MJ, Hodge MR, Gravallese EM, de la Brousse FC, Hoey T, Mickanin C, Baldwin HS, Glimcher LH (1998) The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392:186–190CrossRefPubMed Ranger AM, Grusby MJ, Hodge MR, Gravallese EM, de la Brousse FC, Hoey T, Mickanin C, Baldwin HS, Glimcher LH (1998) The transcription factor NF-ATc is essential for cardiac valve formation. Nature 392:186–190CrossRefPubMed
20.
go back to reference de la Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, Potter J, Wakeham A, Marengere L, Langille BL, Crabtree GR, Mak TW (1998) Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392:182–186CrossRefPubMed de la Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, Potter J, Wakeham A, Marengere L, Langille BL, Crabtree GR, Mak TW (1998) Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 392:182–186CrossRefPubMed
21.
go back to reference Harris CD, Ermak G, Davies KJA (2005) Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product Calcipressin 1 (or RCAN1) in disease. Cell Mol Life Sci 62:2477–2486CrossRefPubMed Harris CD, Ermak G, Davies KJA (2005) Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product Calcipressin 1 (or RCAN1) in disease. Cell Mol Life Sci 62:2477–2486CrossRefPubMed
22.
go back to reference Vega RB, Rothermel BA, Weinheimer CJ, Kovacs A, Naseem RH, Bassel-Duby R, Williams RS, Olson EN (2003) Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc Natl Acad Sci USA 100:669–674CrossRefPubMedPubMedCentral Vega RB, Rothermel BA, Weinheimer CJ, Kovacs A, Naseem RH, Bassel-Duby R, Williams RS, Olson EN (2003) Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc Natl Acad Sci USA 100:669–674CrossRefPubMedPubMedCentral
23.
go back to reference Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, Williams RS (2000) A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 275:8719–8725CrossRefPubMed Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, Williams RS (2000) A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 275:8719–8725CrossRefPubMed
24.
go back to reference Harris CD, Ermak G, Davies KJ (2007) RCAN1-1L is overexpressed in neurons of Alzheimer’s disease patients. FEBS J 274:1715–1724CrossRefPubMed Harris CD, Ermak G, Davies KJ (2007) RCAN1-1L is overexpressed in neurons of Alzheimer’s disease patients. FEBS J 274:1715–1724CrossRefPubMed
25.
go back to reference Lee HJ, Kim YS, Sato Y, Cho YJ (2009) RCAN1-4 knockdown attenuates cell growth through the inhibition of Ras signaling. FEBS Lett 583:2557–2564CrossRefPubMed Lee HJ, Kim YS, Sato Y, Cho YJ (2009) RCAN1-4 knockdown attenuates cell growth through the inhibition of Ras signaling. FEBS Lett 583:2557–2564CrossRefPubMed
Metadata
Title
RCAN1 Mutation and Functional Characterization in Children with Sporadic Congenital Heart Disease
Authors
Xiaoyong Li
Lei Shi
Ming Xu
Xun Zheng
Yiwen Yu
Jing Jin
Publication date
01-02-2018
Publisher
Springer US
Published in
Pediatric Cardiology / Issue 2/2018
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-017-1746-y

Other articles of this Issue 2/2018

Pediatric Cardiology 2/2018 Go to the issue